A breakthrough grape-seed-derived pill could push human life expectancy toward 150 years by purging “zombie cells” from the body.
Shenzhen-based Lonvi Biosciences has unveiled a capsule centered on procyanidin C1 (PCC1), a compound derived from grape seeds designed to target senescent, or “zombie,” cells. These damaged cells stop dividing but remain in the body, triggering inflammation and driving age-related decline. In laboratory settings, mice treated with PCC1 showed a 9.4% increase in overall lifespan, while those who began the regimen early saw their lives extended by a staggering 64%.
By clearing these cellular roadblocks and boosting mitochondrial energy, researchers believe this treatment could fundamentally preserve human vitality well beyond a century.
While the transition from animal models to human application is a significant hurdle, the research signals a major shift in how aging is addressed at a strategic level. China has integrated longevity science into its national planning alongside artificial intelligence and biotechnology, treating the pursuit of extended life as a matter of scientific inevitability. However, experts caution that without human clinical trials, the promise of a 150-year lifespan remains speculative. As the global race to solve aging intensifies, the true test will be whether clearing zombie cells can effectively alter the human biological clock or if the dream of a life-extending pill remains a theoretical hope.
source: Lonvi Biosciences. Single-cell profiling unveils a geroprotective role of Procyanidin C1 in hematopoietic immune system via senolytic and senomorphic effects. NPJ Aging